Precision BioSciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74019P2074
USD
6.52
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
34.20
0.01
0.02
0.03
0.64
0.58
49.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
34.20
0.01
0.02
0.03
0.64
0.58
49.90
Raw Material Cost
0.68
0.67
0.70
0.70
0.76
1.01
1.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
8.70
9.89
10.50
10.76
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.35
0.36
0.36
0.35
0.39
0.26
0.56
Selling and Distribution Expenses
6.87
6.96
8.76
8.19
9.22
8.35
7.99
Other Expenses
0.51
0.28
0.16
0.21
1.51
1.22
1.58
Total Expenditure (Excl Depreciation)
21.70
20.68
21.90
22.14
25.48
21.85
25.75
Operating Profit (PBDIT) excl Other Income
12.5
-20.7
-21.9
-22.1
-24.8
-21.299999999999997
24.1
Other Income
-4.99
0.44
0.43
2.66
0.34
0.89
0.70
Operating Profit (PBDIT)
8.20
-19.55
-20.75
-18.75
-23.75
-19.38
26.23
Interest
0.35
0.36
0.36
0.35
0.39
0.26
0.56
Exceptional Items
12.07
-1.18
-1.71
-0.76
7.15
4.22
8.46
Gross Profit (PBDT)
33.53
-0.66
-0.68
-0.68
-0.12
-0.43
48.52
Depreciation
0.68
0.67
0.70
0.70
0.76
1.01
1.38
Profit Before Tax
19.25
-21.77
-23.52
-20.57
-17.75
-16.43
32.75
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.25
-21.77
-23.52
-20.57
-17.75
-16.43
32.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.25
-21.77
-23.52
-20.57
-17.75
-16.43
32.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.25
-21.77
-23.52
-20.57
-17.75
-16.43
32.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
92.25
16.63
34.05
49.34
56.39
64.87
74.71
Earnings per share (EPS)
1.0
-1.84
-2.13
-2.21
-2.22
-2.25
4.67
Diluted Earnings per share
1.0
-1.84
-2.13
-2.21
-2.22
-2.25
4.67
Operating Profit Margin (Excl OI)
36.57%
-158976.92%
-121538.89%
-76248.28%
-3894.36%
-3693.58%
48.39%
Gross Profit Margin
58.26%
-162292.31%
-126800.0%
-68482.76%
-2662.7%
-2676.04%
68.4%
PAT Margin
56.27%
-167476.92%
-130666.67%
-70913.79%
-2781.35%
-2851.56%
65.63%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 5,600.00% vs -91.43% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 208.47% vs -32.09% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 154.77% vs -81.20% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -25.00% vs -33.33% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Precision BioSciences, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
34.20
0.00
34.20
Other Operating Income
0.00
0.00
0.00
Total Operating income
34.20
0.00
34.20
Raw Material Cost
0.68
0.04
0.64
1,600.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
8.70
0.00
8.70
Power Cost
0
0
0.00
Manufacturing Expenses
0.35
0.00
0.35
Selling and Distribution Expenses
6.87
3.25
3.62
111.38%
Other Expenses
0.51
0.81
-0.30
-37.04%
Total Expenditure (Excl Depreciation)
21.70
11.36
10.34
91.02%
Operating Profit (PBDIT) excl Other Income
12.51
-11.36
23.87
210.12%
Other Income
-4.99
0.24
-5.23
-2,179.17%
Operating Profit (PBDIT)
8.20
-11.09
19.29
173.94%
Interest
0.35
0.00
0.35
Exceptional Items
12.07
-2.37
14.44
609.28%
Gross Profit (PBDT)
33.53
-0.04
33.57
83,925.00%
Depreciation
0.68
0.04
0.64
1,600.00%
Profit Before Tax
19.25
-13.49
32.74
242.70%
Tax
0.00
-0.05
0.05
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
19.25
-13.44
32.69
243.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
19.25
-13.44
32.69
243.23%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.25
-13.44
32.69
243.23%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
92.25
1.06
91.19
8,602.83%
Earnings per share (EPS)
1.00
-0.25
1.25
500.00%
Diluted Earnings per share
1.00
-0.25
1.25
500.00%
Operating Profit Margin (Excl OI)
36.57%
0.00%
0.00
36.57%
Gross Profit Margin
58.26%
0.00%
0.00
58.26%
PAT Margin
56.27%
0.00%
0.00
56.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3.42 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 5,600.00% vs -91.43% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.92 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 188.07% vs 7.23% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 208.47% vs -32.09% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.32 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 166.00% vs 5.66% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 154.77% vs -81.20% in Dec 2024

Quarterly - Interest
Interest 0.03 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -25.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -25.00% vs -33.33% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 36.57%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024